Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Price | Valuation Score | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KRYS | KRYSTAL BIOTECH INC | $161.10 | $9.60 | 1,577.64% | 402.75x | -56.93x | 86.29x | 5.85x | 7.61x | -$603.00k | -0.01% | $778.64M | 28.68 | $4.21B | 235.01 | |
| TGTX | TG THERAPEUTICS INC | $16.19 | $4.88 | 232.07% | 179.89x | -24.16x | 9.84x | 15.58x | 1.29x | -$31.41M | -1.37% | $160.50M | 1.13 | $2.52B | 97.16 | |
| SRPT | SAREPTA THERAPEUTICS INC | $133.66 | $24.26 | 450.89% | 326.00x | 20.66x | 8.95x | 13.14x | 2.13x | -$632.74M | -5.04% | $961.19M | 10.23 | $13.59B | 149.09 | |
| VNDA | VANDA PHARMACEUTICALS INC | $4.88 | $1.65 | 196.03% | 122.00x | 18.07x | 1.45x | 0.52x | 1.20x | $12.42M | 4.43% | $544.91M | 9.50 | $151.97M | 16.26 | |
| CORT | CORCEPT THERAPEUTICS INC | $24.52 | $16.33 | 50.16% | 21.32x | 17.51x | 4.81x | 4.66x | 0.86x | $124.70M | 4.95% | $547.86M | 5.33 | $2.40B | 19.56 | |
| GMAB | GENMAB A | $29.72 | $22.53 | 31.93% | 24.75x | 18.01x | 7.69x | 4.20x | 0.65x | $770.94M | 3.92% | $4.68B | 7.07 | $17.69B | N/A | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $31.57 | $44.42 | -28.94% | 13.43x | 8.18x | 2.90x | 3.48x | 0.35x | $207.65M | 11.59% | $515.39M | 9.08 | $1.65B | 6.95 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $82.44 | $37.26 | 121.24% | 75.63x | 29.34x | 6.30x | 3.09x | 0.92x | $191.82M | 1.23% | $5.07B | 26.87 | $15.99B | 44.45 | |
| HALO | HALOZYME THERAPEUTICS INC | $39.91 | $47.87 | -16.64% | 18.74x | 9.78x | 6.35x | 60.39x | 0.39x | $373.28M | 7.09% | $83.81M | 0.64 | $6.44B | 14.25 | |
| INCY | INCYTE CORP | $53.76 | $67.15 | -19.94% | 16.14x | 9.05x | 3.20x | 2.24x | 0.39x | $790.77M | 6.55% | $5.39B | 24.03 | $8.76B | 7.91 | |
| RPRX | ROYALTY PHARMA PLC | $28.41 | $41.84 | -32.10% | 11.19x | 7.05x | 5.40x | 1.68x | 0.36x | $2.98B | 23.40% | $10.08B | 22.53 | $22.63B | 17.12 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | $2.03 | $40.38 | -94.97% | 2.78x | 0.66x | 0.36x | 0.32x | 0.02x | $10.68M | 7.83% | $433.43M | 6.45 | -$29.09M | -0.53 | |
| EXEL | EXELIXIS INC | $21.90 | $16.15 | 35.57% | 34.22x | 13.60x | 3.57x | 3.00x | 0.61x | $279.60M | 4.25% | $2.13B | 7.08 | $6.32B | 20.21 | |
| JAZZ | JAZZ PHARMACEUTICALS PLC | $110.01 | $169.88 | -35.24% | 21.03x | 4.53x | 1.79x | 1.88x | 0.27x | $1.01B | 14.70% | $3.70B | 59.11 | $11.26B | 9.67 | |
| TECH | BIO-TECHNE CORP | $77.29 | $22.21 | 247.94% | 54.82x | 32.07x | 10.63x | 6.19x | 1.87x | $225.39M | 1.85% | $1.96B | 12.46 | $12.57B | 33.72 | |
| PBYI | PUMA BIOTECHNOLOGY INC | $4.86 | $8.87 | -45.19% | 14.73x | 7.71x | 1.03x | 4.60x | 0.24x | $35.47M | 15.14% | $50.98M | 1.06 | $268.42M | 6.48 | |
| BNTX | BIONTECH SE | $92.72 | $77.34 | 19.89% | 22.04x | 19.56x | 5.31x | 1.00x | 0.60x | $5.07B | 23.01% | $22.01B | 92.57 | $10.10B | 6.67 | |
| MDXG | MIMEDX GROUP INC | $7.37 | $5.58 | 32.16% | 14.17x | 147.40x | 3.23x | 6.99x | 0.95x | $34.30M | 3.18% | $155.73M | 1.06 | $1.06B | 20.86 | |
| CPRX | CATALYST PHARMACEUTICALS INC | $14.72 | $7.55 | 94.91% | 21.97x | 16.36x | 3.93x | 4.47x | 1.33x | $143.37M | 9.16% | $387.88M | 3.65 | $1.60B | 12.54 | |
| NVO | NOVO NORDISK A S | $123.05 | $18.63 | 560.61% | 42.83x | 50.74x | 15.79x | 38.99x | 15.07x | $9.18B | 1.65% | $14.23B | 3.16 | $557.92B | 31.57 | |
| REGN | REGENERON PHARMACEUTICALS INC | $957.00 | $270.78 | 253.43% | 26.50x | 23.55x | 7.88x | 3.91x | 4.62x | $4.06B | 3.94% | $26.99B | 250.38 | $105.55B | 23.20 | |
| UTHR | UNITED THERAPEUTICS CORP | $262.40 | $174.32 | 50.53% | 11.74x | 13.60x | 4.94x | 2.18x | 1.78x | $752.40M | 6.10% | $5.34B | 113.58 | $10.99B | 7.35 | |
| VRTX | VERTEX PHARMACEUTICALS INC | $401.08 | $89.18 | 349.73% | 28.55x | 29.51x | 10.47x | 5.89x | 11.63x | $3.34B | 3.23% | $17.58B | 68.22 | $93.96B | 20.40 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.